Known gBRCA carrier individuals have a higher lifetime risk of developing pancreatic cancer compared to the normal population (with BRCA1: 2.2–3.0%; with BRCA2: 3.0–7.0%) [74,75,76]. This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.